RETRA hydrochloride is an antitumor agent which inhibits tumor cell growth in a mutant p53- and p73-dependent manner in vitro and iin vivo (IC50 = 4 M). It also transcriptionally activates expression of p53-responsive genes and induces activation of effector caspase-3 and caspase-7.
